MyCartis Overview
- Year Founded
-
2014

- Status
-
Private
- Employees
-
51

- Latest Deal Type
-
2ndary - Private
- Investors
-
7
MyCartis General Information
Description
Developer of immuno-diagnostic equipment intended for the clinical user and collaboration with partners to port assays. The company leverages quality analytical performance from conventional immunodiagnostic approaches with the unique capability to quantify and monitor binding reactions in real-time, helping clinical users to get accurate, clinical guidance with its sample.
Contact Information
Website
www.mycartis.net
Formerly Known As
Pronota
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Primary Office
- Industriepark Zwijnaarde 7C
- Flanders
- 9052 Ghent
- Belgium
+32 09 000 00 00
MyCartis Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Secondary Transaction - Private | 000.00 | Completed | Generating Revenue | |||
2. Accelerator/Incubator | 000.00 | Completed | Startup | |||
1. Early Stage VC | 04-Sep-2014 | $19.9M | $19.9M | Completed | Startup |
MyCartis Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of immuno-diagnostic equipment intended for the clinical user and collaboration with partners to port assays.
Diagnostic Equipment
Ghent, Belgium
51
As of 2016
000.00
000000 - 000
000.00
MyCartis Competitors (9)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Illumina | Formerly VC-backed | San Diego, CA | 0000 | 00.000 | 0000 | 00.000 |
00000000 000000000 | Corporation | Fremont, CA | 000 | 0000000000 | ||
0000000000 0000000 | Formerly VC-backed | Cambridge, MA | 0000 | 00000 | 00000000000 | |
00000 00000 000000 | Formerly VC-backed | West Valley City, UT | 000 | 000.00 | 000000&0 | |
00000000 | Venture Capital-Backed | Seattle, WA | 00 | 00000 | 00000000000 | 00000 |
MyCartis Patents
MyCartis Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3512633-A1 | Prefilled cartridge | Inactive | 12-Oct-2016 | 000000000000 | |
US-20200290038-A1 | Prefilled cartridge | Inactive | 12-Oct-2016 | 000000000000 | |
AU-2016347740-A1 | Use of cd146 as a marker of the vascular wall tension | Inactive | 06-Nov-2015 | 0000000000 | |
EP-3371600-A1 | Use of cd146 as a marker of the vascular wall tension | Inactive | 06-Nov-2015 | 00000000000 | |
US-20180321257-A1 | Use of cd146 as a marker of the vascular wall tension | Inactive | 06-Nov-2015 | G01N33/6893 |
MyCartis Signals
MyCartis Investors (7)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Aescap Life Sciences | Mutual Fund | Minority | 000 0000 | 000000 0 | |
Korys Investments | Family Office | Minority | 000 0000 | 000000 0 | |
Participatiemaatschappij Vlaanderen | Asset Manager | Minority | 000 0000 | 000000 0 | |
Rudi Marien | Angel (individual) | Minority | 000 0000 | 000000 0 | |
Valiance | Venture Capital | Minority | 000 0000 | 000000 0 |